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Abstract
This study tested the hypothesis that the
risk for alveolar bone loss is greater, and
bone loss progression more severe, for sub-
jects with poorly controlled (PC) type 2 dia-
betes mellitus (type 2 DM) compared to those
without type 2 DM or with better controlled
(BC) type 2 DM. The PC group had glycosy-
lated hemoglobin (HbAf > 9%; the BC group
had HbAx < 9%. Data from the longitudinal
study of the oral health of residents of the
Gila River Indian Community were analyzed.
Of the 359 subjects, aged 15 to 57 with less
than 25% radiographic bone loss at baseline,
338 did not have type 2 DM, 14 were BC, and
7 were PC. Panoramic radiographs were
used to assess interproximal bone level. Bone
scores (scale 0-4) corresponding to bone loss
qf0%, 1%> to 24%, 25%o to 49%o, 50% to 74%>,
or > 75%o were used to identify the worst bone
score (WBS) in the dentition. Change in worst
bone score at follow-up, the outcome, was
specified on a 4-category ordinal scale as no
change, or a 1-, 2-, 3-, or 4-category increase
over baseline WBS (WBS1). Poorly controlled
diabetes, age, calculus, time to follow-up ex-
amination, and WBS1 were statistically sig-
nificant explanatoiy variables in ordinal
logistic regression models. Poorly controlled
type 2 DM was positively associated with
greater risk for a change in bone score (com-
pared to subjects without type 2 DM) when
the covariates were included in the model.
The cumulative odds ratio (COR) at each
threshold of the ordered response was 11.4
(95%o CI = 2.5, 53.3). When contrasted with
subjects with BC type 2 DM, the COR for
those in the PC group was 5.3 (95%> CI = 0.8,
53.3). The COR for subjects with BC type 2
DM was 2.2 (95%> CI = 0.7, 6.5), when con-
trasted to those without type 2 DM. These re-
sults suggest that poorer glycemic control
leads to both an increased risk for alveolar
bone loss and more severe progression over
those without type 2 DM, and that there may
be a gradient, with the riskfor bone loss pro-
gression for those with better controlled type
2 DM intermediate to the other 2 groups. Ann
Periodontol 1998;3:30-39.
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INTRODUCTION
Diabetes mellitus is a heterogeneous
group of disorders with different causes but
all characterized by hyperglycemia, absolute
or relative insulin deficiency or resistance to
the action of insulin, and the tendency to de-
velop certain long-term complications. The
commonly recognized complications include
accelerated atherosclerosis (macrovascular
disease), diabetic retinopathy, diabetic ne-
phropathy, and diabetic neuropathy.1
There are 4 major types of diabetes, with
type 2 diabetes mellitus (formerly designated
non-insulin-dependent diabetes mellitus)
most prevalent. Approximately 90% to 95%
of the estimated 7.8 million people in the
United States diagnosed with diabetes have
type 2 diabetes (type 2 DM),2 and virtually
all people with diabetes aged > 45 years
have type 2 DM.3 It is also estimated that for
every diagnosed case of type 2 DM, there is
approximately 1 undiagnosed case.3 The
next most common type is type 1 diabetes
mellitus (type 1 DM, formerly designated as
insulin-dependent diabetes mellitus), occur-
ring in 5% to 10% of diagnosed cases of di-
abetes. Diabetes associated with certain
systemic conditions or syndromes comprises
approximately 2% of all diagnosed cases of
diabetes. These conditions include pancre-
atic disease, disease of hormonal etiology,
drug- or chemical-induced conditions, abnor-
malities of insulin or its receptors, certain
genetic syndromes, and other miscellaneous
conditions.4 Approximately 2% to 5% of all
pregnancies have associated gestational di-
abetes mellitus.5
The complications of diabetes, found in
both type 2 DM and type 1 DM, result from
structural and functional changes in sus-
ceptible tissues. These complications rarely
occur in individuals without the metabolic
abnormalities, hyperglycemia and insulin
deficiency (relative or absolute), that char-
acterize diabetes mellitus. There has been
extensive research to characterize the mech-
anisms responsible for the pathogenesis of
both the microvascular and macrovascular
complications, and several mechanisms
have been hypothesized. These mechanisms
include altered myoinositol metabolism,6
non-enzymatic glycosylation,7 altered he-
modynamics,8 and genetic factors.912
However, it is uncertain which of the hy-
pothesized mechanisms, or combinations of
mechanisms, is directly responsible in the
target tissues for the pathogenesis of com-
plications. It is also undetermined whether
different mechanisms are operative in differ-
ent tissues. It is known that not all people
with diabetes experience these complica-
tions and that there is variability in the rate
of development and severity of complica-
tions.
Strong evidence exists to support the no-
tion that people with diabetes have in-
creased risk for Periodontitis. Indeed,
periodontal disease has been recognized as
another complication of diabetes.13 Many
studies have reported an association be-
tween poor glycemic control and increased
Occurrence of Periodontitis,14 29 although a
number have also reported no association.30 42
Most of these studies involve type 1 DM or
do not specify the diabetes type; most are
cross-sectional, thus unable to provide an
estimate of glycemic control-related risk for
poorer periodontal health; few use multivar-
iate analysis; and none using sites or teeth
as units of analysis accounts for extravar-
iation (correlated observation) in the statis-
tical analyses. The extensive variations in
the design, conduct, and analyses of this set
of studies contribute to inconsistencies in
the findings. Consequently, no firm conclu-
sions can be drawn from this collective body
of literature. There are no previous reports
that model risk for alveolar bone loss pro-
gression related to level of glycemic control
of type 2 DM.
The purpose of this study was to test the
hypothesis that the risk for alveolar bone
loss is greater, and bone loss progression
more severe, for subjects with poorly con-
trolled type 2 DM compared to those without
type 2 DM or with better controlled type 2
DM.
MATERIALS AND METHODS
Subjects for these analyses were 359 in-
dividuals, aged 15 to 57, who were part of a
longitudinal study of type 2 DM and perio-
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dontal disease in the Gila River Indian Com-
munity. Full details of this study have been
presented elsewhere.43 45 There were 338
subjects free of diabetes at baseline who did
not develop type 2 DM during the follow-up
period. The other 21 had type 2 DM (14 with
better controlled DM and 7 with poorly con-
trolled DM) at baseline. Type 2 DM was de-
fined as having a plasma glucose concentra-
tion > 200 mg/dL 2 hours after a 75 g oral
glucose load following an overnight fast.
Poorly controlled was defined as glycosylated
hemoglobin (HhAJ values > 9% and better
controlled as HbA, < 9%. Subjects selected
were those who had 20 or more teeth, lost
no teeth during the follow-up period, and
had less than 25% radiographic bone loss at
baseline. The median time to follow-up was
2.3 years; the minimum and maximum fol-
low-up periods were 1.2 and 6.9 years, re-
spectively.
The response variable for these analyses
was change in radiographic bone score, as
determined from panoramic radiographs.
The baseline worst bone score (WBS1) for
the mesial and distal of each tooth was as-
sessed on a 0 to 4 ordinal scale, using a
modified Schei ruler45 with the score corre-
sponding to percentage of root length not
supported by interproximal bone. One value
for each tooth, the greater of the mesial and
distal measurements, was recorded. Bone
scores corresponded to bone loss of 0%, 1%
to 24%, 25% to 49%, 50% to 74%, or > 75%.
Change in bone score category (WBSch), the
outcome of interest in this analysis, was
computed as the greatest difference between
baseline worst bone score (WBS1) and worst
bone score at follow-up (WBS2). This out-
come was specified as a 4-category ordinal
scale representing no change, a 1-category
increase, 2-category increase, or 3- or 4-cat-
egory increase over WBS1.
Glycemic control status, the principal ex-
posure in these analyses, was specified as 2
indicator variables, better control (HbAi <
9%) and poorer control (HbAj > 9%). Addi-
tional dental, behavioral, medical, and dem-
ographic variables were evaluated at their
baseline values for confounding and effect
modification. Age, calculus index,46 plaque
index,47 gingival index,48 and time to follow-
up examination were used in the models as
continuous covariates. Indicator variables
were defined for WBS1 (0% or 1% to 24%),
self-reported alcohol consumption (> 3
drinks/day), smoking (any smoking in the
year preceding baseline), obesity (body mass
index > 27 kg/m2), coronary artery disease,
and gender.
Statistical analyses consisted of contin-
gency table analysis and regression model-
ing. Contingency tables were used to assess
relationships among variables for sparseness
and patterns of possible confounding or effect
modification. Regression modeling consisted
of developing ordinal logistic regression mod-
els with cumulative logits,49 using an ordinal
specification for WBSch, to test the effects of
other covariates on the WBSch-glycemic con-
trol association. Use of cumulative logits to
analyze the ordinal response provided a way
to analyze both the incidence of any change
of periodontal status over time, as well as the
severity of change, where change in periodon-
tal status in subjects was ordinally defined at
follow-up as no change, or a 1-, 2-, 3-, or 4-
category increase. Parameter estimates ob-
tained from this approach also allowed esti-
mating the probability of making any change,
as well as a 1-category leap, 2-category leap,
and so on, over the follow-up period.
The regression models were developed in
stages. First, using a forward stepwise selec-
tion procedure,11 all the dental, behavioral,
medical, and demographic variables consid-
ered to be important risk factors or confound-
ers were included in a model, with the 2
indicator variables for glycemic control forced
to remain in each model tested (the reference
category included all subjects without type 2
DM). This initial selection step resulted in a
preliminary candidate model. Next, each of
the variables that had been previously elimi-
nated in the stepwise selection procedure
was separately retested in this candidate
model and retained if it attained a level of sig-
nificance with P value < 0.05. Following test-
ing for main effects, first-order interaction
terms were tested in the candidate model for
relations between baseline age or glycemic
||Proc Logistic, SAS Institute Inc., Cary, NC.
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•Percentage of subjects shown in parentheses.
control and all the main effects variables and
for relations between baseline periodontal
status and selected covariates. Quadratic
terms were tested for all continuous covar-
iates. Using likelihood ratio tests for the or-
dinal logistic regression models, terms found
not to be statistically significant at the 0.05
level or important as effect modifiers or con-
founders in the modeled relationships were
eliminated. Parameter estimate interpreta-
tion incorporated the point estimate as well
as the 95% confidence interval in testing the
ability to reject the null hypothesis. After ob-
taining a parsimonious model, the model fit
was evaluated by using the likelihood ratio
chi-squared test statistic, score test for the
proportional odds assumption, and residual
analysis.
RESULTS
Table 1 presents selected descriptive base-
line statistics of the subjects without type 2
DM contrasted with 21 subjects with type 2
DM classified by level of glycemic control (i.e.,
better controlled and poorly controlled).
Among subjects with better control, a notably
higher proportion was female, while among
those with poorer control, a somewhat higher
proportion was male. The median ages for
subjects with better control and for those
with poorer control were similar, although
both groups were slightly older than the
group without type 2 DM. The proportion of
current smokers was slightly higher in the
group without type 2 DM compared to the
group with type 2 DM who were better con-
trolled, but there was a notably higher pro-
portion of current smokers in the group with
poorly controlled type 2 DM compared to
both of the other 2 groups. (Data on smoking
status were missing for 2 subjects in the "No
Diabetes" group.) The median number of
teeth was equivalent for the 3 groups, and the
calculus and plaque indices were similar. The
gingival index was similar for those without
type 2 DM and better controlled groups but
slightly lower in the poorly controlled group.
Table 2 shows the bivariate relationships
between degree of WBSch, glycemic control
status, and other selected baseline charac-
teristics. There was a notable trend for the
proportion of subjects experiencing no
WBSch to diminish as glycemic control
status worsened, with 59.5% of those without
type 2 DM, 42.9% of the better controlled,
and only 1 (14.3%) of the poorly controlled
subjects having no WBSch at follow-up. Al-
though the number of subjects with type 2
DM was small in the last 2 categories of
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Table 2. Change in worst bone score by selected baseline characteristics (percentage of subjects in each row of each
variable is shown in parentheses for the categories of change in worst bone score)
Baseline
Characteristics None





























































































Table 3. Cumulative logistic regression model* (No Diabetes is the referent group)




















































*Model evaluation statistics: likelihood ratio chi-squared statistic
proportional odds assumption = 14.3 (12 degrees of freedom), P --
79.4 (6 degrees of freedom),
.2841.
.0001; score test for the
WBSch, there was a tendency for the subjects
with poorer control to have a higher propor-
tion with more severe bone loss (i.e., a 1-,
2-, 3-, or 4-category change). The 3 age
groups in Table 2 reflected a pattern of in-
creasing severity of WBSch as age increased.
The pattern of bone loss for smokers and non-
smokers was equivalent, except possibly the
most severe category. Subjects with some
evidence of radiographic bone loss at base-
line (WBS1 of 1% to 24%), also shown in Ta-
ble 2, tended to have less severe WBSch at
follow-up (i.e., higher proportion with no
change at follow-up and lower proportions in
each of the other WBSch categories). Finally,
subjects with a calculus index score greater
than the median generally exhibited greater
progression of bone loss.
Table 3 shows the results of the final or-
dinal logistic regression model used to test
the hypothesis that the risk for alveolar bone
loss is greater, and bone loss progression
more severe, for subjects with poorly con-
trolled type 2 DM than for those without type
2 DM (the referent group in this model). The
coefficient estimates, P values, odds ratios
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(with 95% confidence limits), and model eval-
uation statistics are shown. This model sug-
gests that subjects with better controlled type
2 DM may not have a statistically signifi-
cantly greater risk for alveolar bone loss pro-
gression than subjects without type 2 DM, as
evidenced by the P value of 0.1750 for the co-
efficient for better control term (HbAi < 9);
the odds ratio of 2.2 includes 1 in its 95%
confidence interval (0.7, 6.5). The model es-
timates that subjects with poorly controlled
type 2 DM (HbA; > 9%) have a significantly
higher risk for alveolar bone loss, as well as
more severe bone loss progression at follow-
up, than subjects without type 2 DM; the
odds ratio is 11.4 (95% CI = 2.5, 53.3). This
final model also estimated significant effects
for time to follow-up and baseline values for
age, calculus, and WBS. There was no signif-
icant risk associated with alcohol consump-
tion, smoking, obesity, systolic blood pres-
sure, coronary artery disease, gender, or
number of teeth in the final model.
Table 4 shows the results of the final or-
dinal logistic regression model used to test
the hypothesis that the risk for alveolar bone
loss over 2 years is greater, and bone loss
progression more severe, for subjects with
poorly controlled type 2 DM than for those
with better controlled type 2 DM. To test this
hypothesis, the model is specified with indi-
cator variables for subjects with poorly con-
trolled type 2 DM {HbA, > 9%) and for those
without type 2 DM. In this table, the referent
group consists of those subjects with better
controlled type 2 DM (HbAi < 9%). This
model shows that subjects with poorly con-
trolled type 2 DM may not have a statistically
significantly greater risk for alveolar bone
loss progression than subjects with better
control, as evidenced by the Pvalue of 0.0751
for the coefficient for the poorer control term
(HbA! > 9%); the odds ratio of 5.3 includes 1
in its 95% confidence interval (0.8, 33.4).
This interpretation is made with caution be-
cause the size of the odds ratio and wide con-
fidence interval having the lower bound at
0.8 suggest that there may indeed be a dif-
ference between those with poorer control
and those with better control, although not
as strong as the contrast between those with
poorer control and those without type 2 DM.
As expected, the remainder of the parameters
estimated by this model mirrors those shown
in Table 3.
Figure 1 contrasts the probabilities of
change in bone score category estimated by
the ordinal logistic regression model (using
the parameter estimates of Table 3). It shows
that the probability of a 1-, 2-, 3-, or 4-cate-
gory change in radiographic worst bone score
was greatest for subjects with poorly con-
trolled type 2 DM (e.g., subjects with poorly
controlled type 2 DM had a probability of
0.29 for a 2-category change, while the prob-
ability for those with better control was 0.16,
and for those without diabetes 0.09). The fig-
ure also shows a gradient in the effect of type
2 DM on the probability of bone loss progres-
sion, with risk increasing as glycemic control
worsens.
DISCUSSION
The results from these analyses provide
strong evidence to support the hypothesis
that the risk for alveolar bone loss over 2
years is greater, and bone loss progression
more severe, for subjects with poorly con-
trolled type 2 DM than those without type 2
DM. The results provide somewhat more
equivocal evidence in testing the hypothesis
that the risk for alveolar bone loss and its se-
verity is greater for those with poorer control
than those with better control. The effect
parameter for those with poorly controlled
type 2 DM (HbA! > 9%), estimated in the
model with better control (HbA! < 9%) as the
referent group in Table 4, is not statistically
significant when a P value < 0.05 is used as
the cut-off. However, the size of the effect
(odds ratio = 5.3), width of the confidence in-
terval (.8, 33.4), and nearness of the lower
boundary of the 95% confidence interval to 1,
as shown in Table 4, suggest that those with
poorer control may have greater risk than
those with better control. The absence of sta-
tistical significance in this case may be due
to the small numbers of subjects with better
control and poorer control, leading to re-
duced power to detect significant differences
in these analyses. The same may hold for the
absence of statistical significance in contrast-
ing the risk for those with better control with
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Table 4. Cumulative logistic regression model* (HbA, < 9% is the referent group)




















































*Model evaluation statistics: likelihood ratio chi-squared
= 14.3 (12 DF), P = .2841.
.79.4 (6 DF), P = .0001; score test for the proportional odds assumption
0 1 2 3or4
Number of categories changed
Figure 1. Probabilities of change in worst bone score category.
those who do not have type 2 DM. Given the
small sample sizes in the poorly controlled
and better controlled groups, the size and
statistical significance of the effect estimated
for the poorly controlled group, and the pres-
ence in the models of other covariates known
to be associated with progression of perio-
dontal diseases, the evidence is strengthened
for the contrast in risk for those with poorly
controlled type 2 DM over those without type
2 DM. Further, the results from these anal-
yses suggest that there may be a gradient in
risk for alveolar bone loss and severity of its
progression, as illustrated in Figure 1, with
the risk for poorer control > risk for better
control > risk for those without type 2 DM.
In general, the direction of the effects for
the other covariates in the logistic regression
models is as expected, except for WBS1. The
models suggest that there may be an inverse
relationship between WBS1 and WBSch at
follow-up; i.e., there was a higher risk of
WBSch in subjects with no measurable ra-
diographic bone loss (maximum WBS = 0%)
than in subjects with maximum WBS of 1%
to 24% at baseline. Papapanou and Wen-
nstrom50 also found an inverse relationship
between baseline radiographic bone level and
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amount of bone loss at follow-üp. However,
Albandar51 reported a direct relationship be-
tween degree of bone loss at baseline and at
follow-up. Consideration of the unit of anal-
ysis- may provide resolution of these seem-
ingly divergent findings. As was the case with
Papapanou and Wennstrom,50 the individual
in the present study is the analytic unit
rather than the tooth or site, as was the case
in Albandar.51
The stringent subject selection criteria em-
ployed in these analyses resulted in a consid-
erable reduction in the number of subjects
with type 2 DM and potentially weakened
statistical power to detect significant differ-
ences between the groups. The motivation for
choosing subjects who had 20 or more teeth
at baseline, lost no teeth during the follow-up
period, had WBS1 < 24%, and whose diabetes
status did not change during the follow-up
period was to reduce the extraneous effects
of other factors as much as possible. These
strict selection criteria could have led to a se-
lection bias. However, the selection bias in
these analyses, if present, would be towards
selecting the "healthiest" of the type 2 DM
subjects, and hence would bias results
against rejecting the null hypothesis. Since
the analyses resulted in a well-fitting model
that permitted rejecting the null hypothesis
for contrasting WBSch in the poorly con-
trolled versus non-type 2 DM groups, the po-
tential selection bias actually provides more
confidence in the conclusions reached.
Prior to accepting the results from the
models presented, several tests were per-
formed to assess the effects of the stringent
selection criteria. Separate data sets with
larger numbers were created to test the con-
sistency of the effect of poorer control where
WBS1 was < 2 (0% to 49%) instead of < 1 (0%
to 24%), where minimum number of teeth at
baseline was 12 rather than 20, and where
subjects with tooth loss were not excluded.
The results (not shown) of models incorpo-
rating these relaxed inclusion criteria were
not superior to those presented here. The
supplemental model that included subjects
who lost teeth during the follow-up period
(but otherwise met the inclusion criteria) had
401 observations and estimated an improve-
ment in the statistical significance for the ef-
fect of being in the better controlled group,
with an Odds ratio of 2.8 (95% CI = 0.99, 7.8;
Pvalue = 0.052). This result further supports
our suggestion of a gradient of risk related to
glycemic control. However, this supplemental
ordinal logistic regression model did not fit
quite as well (score test Pvalue = 0.0678) as
the final model presented. This worsening of
the model fit, combined with the relaxed in-
clusion criteria, lessened our confidence in
using this model as our final model. Hence,
the results of the more conservative analyses
are presented in the tables.
The principal exposure in these analyses
was glycemic control status, formed by di-
chotomizing the continuous values for gly-
cosylated hemoglobin (HbAj. The cut point of
9% or more, used to distinguish those with
poorer control from those with better control,
was chosen because it is near the HbA\ an-
timode in this population.52 A potential limi-
tation in these analyses is choosing a cut
point for the HbA, measures. By dichotomiz-
ing baseline HbA1; subjects with values
slightly above or below the cut point would
tend to be similar with respect to glycemic
control status, although classified as having
a different exposure in the analysis. This im-
posed dichotomous classification of better
versus poorer control could weaken the
power to detect an effect on alveolar bone loss
severity by assigning subjects with similar
baseline glycemic control characteristics to
different exposure categories. To address this
issue, we conducted a supplemental analysis
by creating a "buffer zone" to identify and ex-
clude subjects who had HbA: values from 8%
to 9%. This supplemental analysis excluded
3 subjects, all in the group with better con-
trolled type 2 DM. Even with the loss of 3 of
the better controlled subjects, we observed
minimal changes in the results of the logistic
regression model that was otherwise identical
to the model presented in Table 4. Hence, it
is not likely that misclassification of glycemic
control status had a substantial role in these
analyses.
These results support and extend other re-
ports in the literature describing an associa-
tion between poor glycemic control and
periodontal disease. This study has evaluated
the effects of glycemic control status on both
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the risk for, as well as severity of, periodontal
destruction over time. The temporal sequence
specified in these longitudinal analyses pro-
vides evidence to support a cause-effect re-
lationship. Subjects with poorer glycemic
control had significantly greater risk for al-
veolar bone loss progression, and the pro-
gression was more severe than in subjects
without type 2 DM. Additionally, these anal-
yses suggest that there may be a gradient in
risk for any alveolar bone loss, as well as se-
verity of progression of alveolar bone loss,
with poorly controlled > better controlled >
no type 2 DM.
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